[1] Gregory, R.I. and Shiekhattar, R. (2005) MicroRNA Biogenesis and Cancer. Cancer Research, 65, 3509-3512. http://dx.doi.org/10.1158/0008-5472.CAN-05-0298
[2] Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O’Briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B. and Tewari M. (2008) Circulating MicroRNAs as Stable Blood-Based Markers for Cancer Detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513-10518.
http://dx.doi.org/10.1073/pnas.0804549105
[3] Kosaka, N., Iguchi, H. and Ochiya, T. (2010) Circulating MicroRNA in Body Fluid: A New Potential Biomarker for Cancer Diagnosis and Prognosis. Cancer Science, 101, 2087-2092.
http://dx.doi.org/10.1111/j.1349-7006.2010.01650.x
[4] Sundarbose, K., Kartha, R. and Subramanian, S. (2013) MicroRNAs as Biomarkers in Cancer. Diagnostics, 3, 84-104. http://dx.doi.org/10.3390/diagnostics3010084
[5] Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J. and Lotvall, J.O. (2007) Exosome-Mediated Transfer of mRNAs and MicroRNAs is a Novel Mechanism of Genetic Exchange between Cells. Nature Cell Biology, 9, 654-659. http://dx.doi.org/10.1038/ncb1596
[6] Arroyo, J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F. and Tewari M. (2011) Argonaute2 complexes carry a population of circulating MicroRNAs Independent of Vesicles in Human Plasma. Proceedings of the National Academy of Sciences of the United States of America, 108, 5003-5008.
http://dx.doi.org/10.1073/pnas.1019055108
[7] Moller, M.B., Pedersen, N.T. and Christensen, B.E. (2004) Diffuse Large B-Cell Lymphoma: Clinical Implications of Extranodal versus Nodal Presentation—A Population-Based Study of 1575 Cases. British Journal of Haematology, 124, 151-159. http://dx.doi.org/10.1046/j.1365-2141.2003.04749.x
[8] Lopez-Guillermo, A., Colomo, L., Jimenez, M., Bosch, F., Villamor, N., Arenillas, L., Muntanola, A., Montoto, S., Gine, E., Colomer, D., Bea, S., Campo, E. and Montserrat, E. (2005) Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin. Journal of Clinical Oncology, 23, 2797-2804. http://dx.doi.org/10.1200/JCO.2005.07.155
[9] Lawrie, C.H., Gal, S., Dunlop, H.M., Pushkaran, B., Liggins, A.P., Pulford, K., Banham, A.H., Pezzella, F., Boultwood, J., Wainscoat, J.S., Hatton, C.S. and Harris, A.L. (2008) Detection of Elevated Levels of Tumour-Associated MicroRNAs in Serum of Patients with Diffuse Large B-Cell Lymphoma. British Journal of Haematology, 141, 672-675. http://dx.doi.org/10.1111/j.1365-2141.2008.07077.x
[10] Fang, C., Zhu, D.X., Dong, H.J., Zhou, Z.J., Wang, Y.H., Liu, L., Fan, L., Miao, K.R., Liu, P., Xu, W. and Li, J.Y. (2012) Serum MicroRNAs Are Promising Novel Biomarkers for Diffuse Large B Cell Lymphoma. Annals of Hematology, 91, 553-559. http://dx.doi.org/10.1007/s00277-011-1350-9
[11] Baraniskin, A., Kuhnhenn, J., Schlegel, U., Chan, A., Deckert, M., Gold, R., Maghnouj, A., Zollner, H., Reinacher-Schick, A., Schmiegel, W., Hahn, S.A. and Schroers, R. (2011) Identification of MicroRNAs in the Cerebrospinal Fluid as Marker for Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. Blood, 117, 3140-3146. http://dx.doi.org/10.1182/blood-2010-09-308684
[12] Alencar, A.J., Malumbres, R., Kozloski, G.A., Advani, R., Talreja, N., Chinichian, S., Briones, J., Natkunam, Y., Sehn, L.H., Gascoyne, R.D., Tibshirani, R. and Lossos, I.S. (2011) MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-Chop. Clinical Cancer Research, 17, 4125-4135. http://dx.doi.org/10.1158/1078-0432.CCR-11-0224
[13] Zhong, H., Xu, L., Zhong, J.H., Xiao, F., Liu, Q., Huang, H.H. and Chen, F.Y. (2012) Clinical and Prognostic Significance of miR-155 and miR-146a Expression Levels in Formalin-Fixed/Paraffin-Embedded Tissue of Patients with Diffuse Large B-Cell Lymphoma. Experimental and Therapeutic Medicine, 3, 763-770.
[14] Culpin, R.E., Sieniawski, M., Proctor, S.J., Menon, G. and Mainou-Fowler, T. (2013) MicroRNAs Are Suitable for Assessment as Biomarkers from Formalin-Fixed Paraffin-Embedded Tissue, and miR-24 Represents an Appropriate Reference MicroRNA for Diffuse Large B-Cell Lymphoma Studies. Journal of Clinical Pathology, 66, 249-252. http://dx.doi.org/10.1136/jclinpath-2012-201021
[15] Lawrie, C.H., Soneji, S., Marafioti, T., Cooper, C.D., Palazzo, S., Paterson, J.C., Cattan, H., Enver, T., Mager, R., Boultwood, J., Wainscoat, J.S. and Hatton, C.S. (2007) MicroRNA Expression Distinguishes between Germinal Center B Cell-Like and Activated B Cell-Like Subtypes of Diffuse Large B Cell Lymphoma. International Journal of Cancer, 121, 1156-1161. http://dx.doi.org/10.1002/ijc.22800
[16] Xu, L., Yang, B.F. and Ai, J. (2013) MicroRNA Transport: A New Way in Cell Communication. Journal of Cellular Physiology, 228, 1713-1719. http://dx.doi.org/10.1002/jcp.24344
[17] Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y. and Ochiya, T. (2010) Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells. The Journal of Biological Chemistry, 285, 17442-17452. http://dx.doi.org/10.1074/jbc.M110.107821
[18] Yoshioka, Y., Kosaka, N., Konishi, Y., Ohta, H., Okamoto, H., Sonoda, H., Nonaka, R., Yamamoto, H., Ishii, H., Mori, M., Furuta, K., Nakajima, T., Hayashi, H., Sugisaki, H., Higashimoto, H., Kato, T., Takeshita, F. and Ochiya, T. (2014) Ultra-Sensitive Liquid Biopsy of Circulating Extracellular Vesicles Using ExoScreen. Nature Communications, 5, Article No. 3591. http://dx.doi.org/10.1038/ncomms4591
[19] Xi, Y., Nakajima, G., Gavin, E., Morris, C.G., Kudo, K., Hayashi, K. and Ju, J. (2007) Systematic Analysis of MicroRNA Expression of RNA Extracted from Fresh Frozen and Formalin-Fixed Paraffin-Embedded Samples. RNA, 13, 1668-1674. http://dx.doi.org/10.1261/rna.642907
[20] Li, J., Smyth, P., Flavin, R., Cahill, S., Denning, K., Aherne, S., Guenther, S.M., O’Leary, J.J. and Sheils, O. (2007) Comparison of miRNA Expression Patterns Using Total RNA Extracted from Matched Samples of Formalin-Fixed Paraffin-Embedded (FFPE) Cells and Snap Frozen Cells. BMC Biotechnology, 7, 36.
http://dx.doi.org/10.1186/1472-6750-7-36
[21] Munch-Petersen, H.D., Ralfkiaer, U., Sjo, L.D., Hother, C., Asmar, F., Nielsen, B.S., Brown, P., Ralfkiaer, E. and Gronbaek, K. (2015) Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma. Applied Immunohistochemistry & Molecular Morphology, 23, 188-195.
http://dx.doi.org/10.1097/PAI.0000000000000073
[22] Kosaka, N., Iguchi, H., Yoshioka, Y., Hagiwara, K., Takeshita, F. and Ochiya, T. (2012) Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs. The Journal of Biological Chemistry, 287, 1397-1405. http://dx.doi.org/10.1074/jbc.M111.288662
[23] Qin, Q., Wei, F.R. and Li, B.S. (2014) Multiple Functions of Hypoxia-Regulated miR-210 in Cancer. Journal of Experimental & Clinical Cancer Research, 33, 50. http://dx.doi.org/10.1186/1756-9966-33-50
[24] Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C. and Croce, C.M. (2006) A MicroRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proceedings of the National Academy of Sciences of the United States of America, 103, 2257-2261. http://dx.doi.org/10.1073/pnas.0510565103
[25] Aqeilan, R.I., Calin, G.A. and Croce, C.M. (2010) MiR-15a and miR-16-1 in Cancer: Discovery, Function and Future Perspectives. Cell Death and Differentiation, 17, 215-220.
http://dx.doi.org/10.1038/cdd.2009.69
[26] Li, H., Hui, L. and Xu, W. (2012) MiR-181a Sensitizes a Multidrug-Resistant Leukemia Cell Line K562/A02 to Daunorubicin by Targeting BCL-2. Acta Biochimica et Biophysica Sinica, 44, 269-277.
http://dx.doi.org/10.1093/abbs/gmr128
[27] Neilson, J.R., Zheng, G.X., Burge, C.B. and Sharp, P.A. (2007) Dynamic Regulation of miRNA Expression in Ordered Stages of Cellular Development. Genes & Development, 21, 578-589.
http://dx.doi.org/10.1101/gad.1522907
[28] Wickramasinghe, N.S., Manavalan, T.T., Dougherty, S.M., Riggs, K.A., Li, Y. and Klinge, C.M. (2009) Estradiol Downregulates miR-21 Expression and Increases miR-21 Target Gene Expression in MCF-7 Breast Cancer Cells. Nucleic Acids Research, 37, 2584-2595. http://dx.doi.org/10.1093/nar/gkp117
[29] Kelly, P.N. and Strasser, A. (2011) The Role of BCL-2 and Its Pro-Survival Relatives in Tumourigenesis and Cancer Therapy. Cell Death and Differentiation, 18, 1414-1424.
http://dx.doi.org/10.1038/cdd.2011.17
[30] Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T. and Patel, T. (2007) MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology, 133, 647-658. http://dx.doi.org/10.1053/j.gastro.2007.05.022
[31] Weiland, M., Gao, X.H., Zhou, L. and Mi, Q.S. (2012) Small RNAs Have a Large Impact: Circulating MicroRNAs as Biomarkers for Human Diseases. RNA Biology, 9, 850-859.
http://dx.doi.org/10.4161/rna.20378